FSD Pharma Added to Leading Cannabis ETF With Significant 1.9% Weighting
27 Setembro 2018 - 8:30AM
InvestorsHub NewsWire
Toronto, ON -- September 27, 2018
-- InvestorsHub NewsWire -- FSD Pharma Inc. (“FSD
Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is
pleased to announce that Horizons ETFs Management (Canada) Inc.
(“Horizons ETFs”) has added the Company to
the Horizons Marijuana Life
Sciences Index ETF ("HMMJ:TSX") as
part of the quarterly rebalance of the constituent holdings of
HMMJ. The Company stock has a 1.9% weighting in HMMJ. According to
Horizons ETFs, “As at September 5, 2018, HMMJ had reached over
CAD $1 billion in assets under management – a rare
achievement for the Canadian ETF
marketplace”.1
“We are thrilled to be included in HMMJ, which is
the largest ETF offering direct exposure for investors to North
American life sciences companies that have significant business
activities in the marijuana industry. FSD Pharma expects to
continue to deliver on its current business strategy and expansion
plan in preparation for adult-use legalization on October 17,
2018,” said Anthony Durkacz, Director of FSD
Pharma.
[1]
http://www.newswire.ca/en/releases/archive/September2018/26/c3045.html
About FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) (FRA:
0K9)
FSD Pharma through its wholly-owned subsidiary FV Pharma, is a
licensed producer of marijuana under the Access to Cannabis for
Medical Purposes Regulations (ACMPR) having received its
cultivation license on October 13, 2017. Headquartered at the
former Kraft plant in Cobourg, Ontario, approximately an hour's
drive from Toronto, FV Pharma management's mission is to transform
the facility into the largest hydroponic indoor cannabis facility
in the world. FV Pharma intends to target all legal aspects of the
cannabis industry, including cultivation, processing,
manufacturing, extracts and research and development.
Forward-Looking
Information
Certain statements contained in this press release
constitute forward-looking information. These statements relate to
future events or future performance. The use of any of the words
"could", "intend", "expect", "believe", "will", "projected",
"estimated" and similar expressions and statements relating to
matters that are not historical facts are intended to identify
forward-looking information and are based on the Corporation's
current belief or assumptions as to the outcome and timing of such
future events. Actual future results may differ materially. In
particular, this release contains forward-looking information
relating to the development of the Corporation's indoor cannabis
facility and its business goals and objectives. The forward-looking
information contained in this press release is made as of the date
hereof, and the Corporation is not obligated to update or revise
any forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Because of the risks, uncertainties and
assumptions contained herein, investors should not place undue
reliance on forward looking-information. The foregoing statements
expressly qualify any forward-looking information contained
herein.
Additional Information
Anthony Durkacz
Director, FSD Pharma Inc.
anthony@firstrepubliccapital.com
416-720-4360
Contact
Information
Investor Relations
Email: IR@fsdpharma.com
Website: www.fsdpharma.com
Neither the Canadian Securities Exchange nor its
regulation services provider accept responsibility for the adequacy
or accuracy of this release.
SOURCE FSD Pharma
Inc.
Global X Marijuana Life ... (TSX:HMMJ)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Global X Marijuana Life ... (TSX:HMMJ)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
